Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

A pharmacist-led comprehensive medication assessment shows that a high number of older oncology patients use multiple and/or inappropriate medications. The findings were published online March 23 in the Journal of Clinical Oncology.

Multiple, Inappropriate Meds Taken by Older Cancer Patients

A pharmacist-led comprehensive medication assessment can optimize meds
Early initiation of palliative care interventions improves survival and caregiver burden in advanced cancer

Early Palliative Care Improves Survival in Advanced Cancer

Second study shows benefits for caregivers with early palliative care intervention
Fit middle-aged men appear less likely to develop lung and colorectal cancer in later life than their out-of-shape peers. And if they do develop cancer

Cancer Risk Down for Men With High Midlife Fitness

Study shows lower risk of lung, colon tumors at 65 and older
There is a considerable gap between patient expectations and current practices for provision of information relating to radiation use in medical imaging tests

Patients Expect More Info About Tests Involving Radiation

Gap between patient expectations, current practices for provision of information about radiation use
Obesity takes a huge toll on health

Cancer Odds Up 40 Percent in Obese Women

However, researchers stress that losing excess weight can lower the odds again
Estimates of cancer incidence for 2011 in the United States show that about two-thirds of those with cancer survive five or more years after diagnosis

CDC Releases Estimates of Cancer Incidence, Survival for 2011

Sixty-five percent of those with cancer survived five years or more; survival lower among blacks
Patients with low-risk prostate or breast cancer may have higher or lower odds of getting an unnecessary imaging based on geography

Where You Live May Impact Use of Unnecessary Imaging

Doctors tend to order more imaging technologies in the Northeast, researchers found
Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma.

FDA Approves Unituxin for High-Risk Neuroblastoma

First approval for a therapy aimed specifically to treat the rare pediatric cancer
The U.S. Food and Drug Administration has approved Zarxio (filgrastim-sndz)

FDA Approves First Biosimilar Drug in U.S.

Zarxio is highly similar to long-sanctioned cancer drug

February 2015 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2015. This roundup includes...